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Bone primary tumors, such as osteosarcoma, are highly aggressive pediatric tumors
that in 30% of the cases develop lung metastasis and are characterized by poor
prognosis. Bone is also the third most common metastatic site in patients with
advanced cancer and once tumor cells become homed to the skeleton, the disease is
usually considered incurable, and treatment is only palliative. Bone sarcoma and bone
metastasis share the same tissue microenvironment and niches. 3D cultures represent
a new promising approach for the study of interactions between tumor cells and
other cellular or acellular components of the tumor microenvironment (i.e., fibroblasts,
mesenchymal stem cells, bone ECM). Indeed, 3D models can mimic physiological
interactions that are crucial to modulate response to soluble paracrine factors, tumor
drug resistance and aggressiveness and, in all, these innovative models might be able
of bypassing the use of animal-based preclinical cancer models. To date, both static and
dynamic 3D cell culture models have been shown to be particularly suited for screening
of anticancer agents and might provide accurate information, translating in vitro cell
cultures into precision medicine. In this mini-review, we will summarize the current
state-of-the-art in the field of bone tumors, both primary and metastatic, illustrating the
different methods and techniques employed to realize 3D cell culture systems and new
results achieved in a field that paves the way toward personalized medicine.
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INTRODUCTION
Cancer is a complex disease that thrives in a heterogeneous and adaptive tumor microenvironment
(Park et al., 2014). Bone sarcomas and bone metastasis (BM) share the same environment and the
niche, where tumor cells can seed and proliferate. Osteosarcoma (OS), chondrosarcoma (CS), and
ewing sarcoma (ES) are the most common malignant primary bone tumors, accounting for 70% of
all such malignancies. Despite the advent of chemotherapy has widely improved patient survival,
sarcomas are still considered deadly and, in a high percentage of cases, incurable diseases (Lewis,
2009). Similarly, BM form when carcinoma cells have homed to the skeleton and, at this stage,
the disease is usually considered incurable, treatment with current modalities is only palliative and
often associated to uncomfortable side effects (Fornetti et al., 2018).
Bone sarcomas are a disease of mesenchymal origin; they originate in the bone, where the
mesenchymal stem cells (MSC) are both ontogenic progenitor tumor cells (Mohseny et al., 2009;
Lye et al., 2016) and stromal cells that participates to tumor development (Xiao et al., 2013; Cortini
et al., 2017). In the bone, the tumor-supporting stroma is formed by osteoblasts (the bone forming
cells deriving from MSC), osteoclasts (the bone resorbing cells), endothelial and immune cells,
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and MSC. Osteoclasts adhere to bone surface and the spectrum
of factors involved in their activation may depend on tumor type.
As an example, osteoclasts can be metabolically fueled directly
by tumor cells (Lemma et al., 2016, 2017) or also stimulated
by tumor-induced osteoblasts (Sousa and Clezardin, 2018). In
OS, the presence of osteoclasts in the tumor microenvironment
may foster the osteoblastic behavior of tumor cells and increase
their aggressiveness (Costa-Rodrigues et al., 2011) and is
considered a bad prognostic factor (Salerno et al., 2008).
Similarly, in BM, the pathogenic process forms when the delicate
balance between bone deposition and resorption is disrupted
(Alfranca et al., 2015).
Given the complexity and heterogeneity of bone tumors, the
therapeutic strategies aimed at their eradication has exhibited
a consistent slow-down to respect to many other carcinomas.
Clearly, a better understanding of bone cancer oncogenesis is
warranted to overcome drug resistance and improve low survival
rate. A number of obstacles impede the study of bone cancers
with the current means. These include the physical difficulty
of manipulating bone as a tissue, the rarity of the tumors for
sarcoma, the difficulties of obtaining tumor tissue fragments from
human patients for BM, and the limited number of models that
effectively mimic human disease. For all these reasons, the need
for new cell models for bone cancers is becoming crucial.
In this review, we focused on the cellular models that are
currently available for the study of BM or sarcomas. Such models
have long been restricted to the two dimensions (2D) of dishes –
an obvious obstacle to investigating structure and organization in
cultured cells. However, a variety of 3D cell culture methods have
recently emerged and are changing the way that multicellular
systems are modeled.
ADVANCES IN 2D SYSTEMS
For decades, monolayer cultures have been the leading light in
wet biology; Harrison (1907) developed the first cell culture from
a nerve fiber in 1907 and demonstrated that tissue specimens
could live out of the body for as long as a 4 weeks time. Since
then, 2D monolayers have been worldwide extended and the
culture technique substantially improved. Nowadays, monolayer
cultures have been upgraded for the study of single or multiple
populations. Co-seeding, transwell membranes and conditioned
culture medium are examples of how cells can be easily handled.
Cancer cells can be treated with conditioned medium of other
cells that play a consistent role in tumor growth (i.e., fibroblasts
or MSC) (Sasser et al., 2007; Iser et al., 2016). Transwell allows
the culturing of two cell types seeded in separate compartments
(Figure 1; Chiovaro et al., 2015; Avnet et al., 2017). Lastly, co-
seeding two different cell population in the same compartment is
also possible, but discrimination of the studied effect on one of
the two populations requires the physical separation of the cells
that is expensive and not always possible (Molloy et al., 2009).
Despite this, differences in cell morphology, migration,
polarization, interaction with the ECM but also cell metabolism
and regional genotypic and phenotypic changes (Dhiman
et al., 2005; Chitcholtan et al., 2013; Russell et al., 2017),
or chemoresistance (Colella et al., 2018) are often far from being
confirmed in 3D models. Altogether, these difference are surely
due to the lack of spatial relationships and adequate culture
conditions. Among the others, one example is that cells respond
differently to hard substrates like lab plastic than they do on softer
ones that resemble the ECM (Engler et al., 2006).
THE UPGRADE TO THE IN VITRO
THIRD DIMENSION
Three dimensional architecture is one of the main issues at the
basis of tissue and organ formation; this level of complexity
starts during embryonic development and further enhances with
cell-to-cell contacts that pose the basis to intracellular functions
(Fitzgerald et al., 2015). Furthermore, cells are surrounded by an
ECM that crucially determines cell differentiation, proliferation,
and homeostasis (Kinney et al., 2014). An ideal 3D culture
model should thus properly mimic not only oncogenesis,
and maintenance of tumor cell growth, but also imitate the
interactions between cells intermingled within the ECM. To
date, with this aim, several technologies have been developed
and explored: static 3D cultures include the seeding of cells in
spheroid-like structure without the extracellular matrix, and the
seeding of cells in matrices or scaffolds, made of natural or
synthetic biomaterials (Figure 1); dynamic 3D cultures include
either spheroids or scaffolds cultured in bioreactors, and the
seeding of cells in microfluidic perfused devices (Figure 1).
Spheroids
One of the pioneer studies that has opened the field to 3D cultures
is the work by Sutherland et al. (1971); they were among the first to
observe that lung cells grown in suspension would form spheroids
that develop with an outer zone containing proliferating cells,
a poorly nourished and oxygenated intermediate zone containing
few cells in mitosis, and a central zone of necrosis, a typical feature
of physiological tumor masses. Forced-floating spheroids are the
simplest method to generate spheroids: cells are prevented to
attach to the well bottom, resulting in floating aggregates and
cell-cell contacts. The hanging-drop method is the most widely
used and is a static technology (Kelm et al., 2003). Adversely,
rotating cell culture bioreactor, spinner flasks or stirred-tank
cultures (Santo et al., 2016) force homogenous spheroid formation
by continuous agitation (Breslin and O’Driscoll, 2013). Also in
this case, spheroids can be formed by a single cell type or can
mimic interactions between multiple cells, such as tumor and
stromal cells (Ishiguro et al., 2017). These culture systems are
highly reproducible and have low production costs; already in
1971 it was clear that spheroids had the potential to be used for
drug screening or to test radiation therapies (Sutherland et al.,
1971). Despite the advantages, not all cell lines form spheroids
and some form only unpredictable cell aggregates.
Matrices and Scaffolds
As for spheroids, cells seeded into matrices or on scaffolds can be
cultured either in static or dynamic cultures using rotating cell
culture bioreactors.
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FIGURE 1 | Schematic representation of the different and most used 2D and 3D in vitro culture systems.
A hydrogel-based matrix is a network of physically or
chemically cross-linked polymer molecules of hydrophilic nature
that allows to retain large amounts of water (Ahmed, 2015)
and provide a 3D biomimetic environment supporting cell
proliferation and differentiation (Peck and Wang, 2013). The
major advantage of hydrogels is their customization according
to the specific features of the ECM. As an example, hydrogels
can be designed to shrink or swell based on the environmental
stimuli that they receive (Ahmed, 2015), and can be easily
enriched with specific cell adhesion ligands to mimic soft tissues.
Hydrogels are of synthetic or natural origin (Li and Kumacheva,
2018), and are mainly based on matrigel, collagen or fibrin.
Matrigel derives from a mouse sarcoma and has the most
heterogeneous composition. The chief components are structural
proteins such as laminin, nidogen, collagen, and heparan sulfate
proteoglycans. Matrigel polymerization depends on temperature.
Collagen-based hydrogels rely also on pH and plays a crucial
role in cancer progression and is the most common protein
of mammalian ECM. However, the pH-dependency makes
collagen-based hydrogels unsuitable for the study of the effects
of tumor acidosis, a feature that is crucial for the development of
bone cancer (Cortini et al., 2017; Avnet et al., 2019), or of cancer-
induced bone pain (Yoneda et al., 2015; Di Pompo et al., 2017).
Traditionally described as tools made of polymeric biomate-
rials, 3D scaffolds have the advantage to provide recapitulation
of the ECM by providing, like hydrogels, attachment sites and
interstitial space for the cells that can grow and proliferate,
forming 3D structures (Breslin and O’Driscoll, 2013). Scaffold
stiffness can be tuned to influence cell adhesion, proliferation
and activation (Keogh et al., 2010). Materials used for scaffold
fabrication must be biocompatible and must induce molecular
biorecognition from cells (Carletti et al., 2011). ECM-mimicking
biomaterials are made of collagen, hyaluronan, matrigel, elastin,
laminin-rich-extracellular matrix, and also alginate, chitosan,
silk and are considered as the most biocompatible. Synthetic
biomaterials include polyethylen glycol, hyaluronic acid-PEG,
polyvinyl alcohol, polycaprolactone, or two-phase systems such
as polyethylene glycol-dextran. A number of biomaterials, such
as ceramics, can fall in the natural or synthetic category
(Thakuri et al., 2018).
Microfluidic Devices
Recent advancements in tissue engineering have led to the
development of living multicellular microculture systems, which
are maintained in controllable microenvironments and function
with organ level complexity [for an extensive review see Huh
et al. (2011)]. The applications of these “on-chip” technologies are
becoming increasingly popular for cancer studies (Sontheimer-
Phelps et al., 2019). Continuous perfusion of media through the
microfluidic network is the major innovation in these systems
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(Chung et al., 2017) since it mimics blood flow and enables
exchange of nutrients, oxygen and metabolites with the blood
tissue that are crucial for modeling living cancer tissues. Invading
cells detaching from a solid tumor are exposed to the novel
microenvironment of the circulatory system. Depending on the
size of the vessel, the blood flow velocity can reach 0.03–40 cm/s,
with arterial hemodynamic shear-force of 4.0–30.0 dyn/cm2 and
venous shear-force of 0.5–4.0 dyn/cm2 (McCarty et al., 2016).
Therefore, tumor cells must promptly adapt from static growth
to fluid shear stress (Mitchell and King, 2013; Phillips et al.,
2014), a condition that is far from being taken into account on
static cultures. Until few years ago, microplates supported only
2D environments (Wu et al., 2010). More recently, the third
dimension has been introduced to support 3D aggregates (Toh
et al., 2007; van Duinen et al., 2015; Lanz et al., 2017). Finally,
microfluidics has allowed the design and the development of
self-organized organ-like cell aggregates that originate from
multipotent stem cells, the organoids, and has opened a whole
new level of biomimicry to be achieved (Yu et al., 2019).
Representative examples are the blood brain barriers, the 3D
neuronal networks, the kidney, liver or the intact gut epithelium
or, when mentioning cancer tissues, glioma, breast cancer or
sarcoma models (Sontheimer-Phelps et al., 2019).
This technology has the power to add multiple cell lines
in the same chip. As an example, it is possible to mimic the
tumor-endothelial cells interaction that is fundamental for the
metastasization process, including angiogenesis, intravasation
and cancer cell colonization (Zervantonakis et al., 2012).
Likewise, microfluidics have been thoroughly studied to
better recapitulate the cancer cell-immune cell interactions,
with the ultimate aim of increasing knowledge on cancer
immunotherapies (Boussommier-Calleja et al., 2016).
Finally, formation of 3D spheroids by using hanging drops
have been combined to microfluidic platforms for drug testing
or chemoresponses assays (Marimuthu et al., 2018). The next
big challenge is the full validation of these models and
subsequently the implementation in drug development pipelines
of the pharmaceutical industry and ultimately in personalized
medicine applications.
STUDYING THE PATHOGENESIS OF
TUMOUR NICHE IN 3D IN VITRO
SYSTEMS OF BONE CANCERS
Many papers have discussed the importance of switching from
2D to 3D cultures in a number of tumor cell lines (Praharaj
et al., 2018), including bone sarcoma (De Luca et al., 2018).
Novel models have now been acquainted also for bone cancers,
and for tumor-related bone microenvironment (Table 1), and
that include 3D tumor-resembling structure endothelial or
fibroblastic cells in order to develop antiangiogenic therapies
and to better understand vasculature expansion (Lee et al., 2006;
Reddy et al., 2008; de Nigris et al., 2013). 3D OS cells have
been combined with 2D endothelial HUVEC cells to form a
well-organized network, including tubule-like structures that
infiltrated the tumor spheroids, like new vessels in vivo. In this
model, HUVEC proliferation and expression of angiogenesis-
associated genes was possible induced by VEGF secretion from
quiescent OS cells, embedded in matrix at the center of the
spheroid, and stressed by the hypoxic core (Chaddad et al.,
2017). The vasculature also seemed to direct the reactivation of
dormant disseminated tumor cells. Targeting the vascular niches
in such early steps of BM delays or even prevents the metastatic
relapse (Kusumbe, 2016). Likewise, a functional tri-culture has
been developed for studying metastatic breast cancer that has
spread to the bone. This includes a stable vascular networks
within a 3D native bone matrix cultured on a microfluidic
chip; this niche-on-a-chip is characterized by controlled flow
velocities, shear stresses, and oxygen gradients. Interestingly,
MSC, which have undergone phenotypical transition toward
perivascular cell lineages, support the formation of capillary-like
structures lining the vascular lumen (Marturano-Kruik et al.,
2018). MSC are associated with the tumor microenviroment since
they are recruited by tumor cells from the bloodstream and are
a considerable component of the general host response to tissue
damage caused by cancer cells (Cortini et al., 2016; Avnet et al.,
2017; Cortini et al., 2017). In another breast cancer metastatic
model, MSC stimulate tumor extravasation and activation of the
cancer cell receptor CXCR2 and the bone-secreted chemokine
CXCL5 (Bersini et al., 2014). Chemokines and interleukins are
also responsible for chemo-attraction of immune cells that, once
recruited to the niche, become part of the tumor bulk and play
a fundamental role in the tumor TME. Microfluidic platforms
retain also the possibility to monitor immune cell migration and
analyze their contribution to the formation of the metastatic
niche through spatial compartmentalization (Gopalakrishnan
et al., 2015; Boussommier-Calleja et al., 2016).
Microfluidics have been also used to successfully recreate
the complex bone marrow TME (Torisawa et al., 2014). The
microchip device included two different compartments: one
for the specific growth of osteoblasts and one for medium
change. Because osteoblastic tissues require long-term cultures,
this design was proven successful as it allowed the formation
of a thick mineralized osteoblastic tissue in vitro in a 1 month
time period (Hao et al., 2018). The bone niche can be also
recreated by using bone scaffolds (Marturano-Kruik et al., 2016).
In ES, for example, cell growth rate is far slower in vivo than
that observed in vitro, thereby more likely reproducing reliable
growth conditions (Fong et al., 2013) and mimicking critical
signaling cascades, such as the IGF-1R/PI3K7mTOR signaling
pathway (Lamhamedi-Cherradi et al., 2014).
ASSAYING CHEMORESISTANCE IN 3D
IN VITRO SYSTEMS OF BONE CANCERS
Arai et al. (2013) found that spheroid cells displayed more
chemoresistance to doxorubicin corresponding to higher IC50
values than conventional monolayer cells (Baek et al., 2016a)
in more than 11 OS cell lines. Similarly, Baek et al. (2016b)
confirmed that OS cells were more chemoresistant in 3D
compared to 2D culture. Similar results were obtained also
with cisplatin. Likewise, the use of MG-63 spheroids effectively
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TABLE 1 | 3D models for bone cancers.
3D model Tumor setting Relevance References
3D collagen gel system containing
osteoblast-like cells
Metastasis from endometrial,
prostate and breast cancer
Prostate cancer cells produced
morphological evidence of blastic
reaction and evidence of local invasion
Sourla et al., 1996
3D hybrid hydrogel system composed
of collagen and alginate
Invasive breast cancer
Osteosarcoma
Human mammary fibroblast cells facilitated
migration of breast cancer cells out of
spheroids and into the surrounding matrix
Thakuri et al., 2018
3D spheroids in combination with 2D
endothelial cells
Formation of tubule-like structures that
mimic vessel sprouting and angiogenesis
Chaddad et al., 2017
Microfluidic niche-on-a-chip Metastatic breast cancer Formation of a self-assmebled vasculature
network supported by MSC
Marturano-Kruik et al., 2018
Triculture system in microfluidics Metastatic breast cancer Extravasation and micrometastasis
generation of breast cancer cells within a
bone-like microenvironment
Bersini et al., 2014
Microfluidics bone-marrow-on-a-chip Hematological diseases Analysis of drug responses and toxicity Torisawa et al., 2014
Microfluidics bone-on-a-chip Metastatic breast cancer Interaction between cancer cells and bone
matrix that lead to tumor colonization
Hao et al., 2018
Bioreactors Ewing sarcoma Recreation of the bone niche that mimics
native tumor properties
Marturano-Kruik et al., 2016
Bone scaffold Ewing sarcoma Analysis of cell cytotoxicity to respect to 2D Fong et al., 2013
Spheroids Osteosarcoma Analysis of chemoresistance Arai et al., 2013
Spheroids Osteosarcoma Analysis of cell cytotoxicity to doxorubicin Baek et al., 2016a
Spheroids Osteosarcoma Analysis of cell cytotoxicity to cisplatin Baek et al., 2016b
Spheroids Osteosarcoma Analysis of cell chemoresistance to
oxidovanadium(IV)
Leon et al., 2016
Spheroids Chondrosarcoma Analysis of cell chemoresistance to
doxorubicin and mafosfamide
Monderer et al., 2013
Spheroids Chondrosarcoma Analysis of cell cytotoxicity to respect to
salinomycin
Perut et al., 2018
Microfluidics co-culture of tumor
and MSC
Ewing sarcoma Resistance of tumor cells to IGF-1R
inhibitors due to the presence of MSC
Santoro et al., 2017
predicted the cytotoxicity of oxidovanadium(IV) in vivo models
(Leon et al., 2016). 3D CS cultures are resistant to doxorubicin
and mafosfamide, when compared to standard monolayer
cultures (Monderer et al., 2013). However, the use of 3D
spheroids allowed to reveal that treatment with the ionophore
salinomycin, previously uncharacterized for its effects on CS,
significantly enhanced the cytotoxic effect to doxorubicin in 3D
structures (Perut et al., 2018).
Finally, drug sensitivity of tumor cells might be strongly
affected by microenvironmental factors that include the presence
of MSC (Avnet et al., 2017; Senthebane et al., 2017), also when co-
cultured with cancer cells in 3D structures. As an example, the 3D
assembly of ES cells with MSC elicits ligand-mediated activation
of the insulin-like growth factor-1 receptor (IGF-1R), thereby
mediating resistance to IGF-1R inhibitors (Santoro et al., 2017).
FROM PRECLINICAL MODELS TO
CLINICAL VALIDATION
The main aim of expanding the knowledge on culture systems
is to be able to translate the molecular features of the 3D cell
cultures of individual patients using them as a platform for
drug screening and to identify biomarkers and new drug targets
(Breslin and O’Driscoll, 2013). Findings using 3D models that
more accurately reflect human sarcoma biology are likely to
translate into improved clinical outcomes (Gao et al., 2017). As an
example moving in this direction, Pauli and colleagues have made
a great effort in describing a precision-medicine platform that
integrates whole-exome sequencing with a living biobank that
enables high-throughput drug screens on patient-derived tumor
organoids. To date, 56 tumor-derived organoid cultures and 19
patient-derived xenograft models have been established from the
769 patients enrolled in an Institutional Review Board–approved
clinical trial (Pauli et al., 2017). These types of approach have the
potential not only to select the appropriate therapeutic option,
but also to improve the knowledge on the molecular cues that lay
at the basis of tumor development.
CONCLUSION
Three dimensional models offer early promise in establishing
robust preclinical platforms for the identification of crucial mole-
cular pathways and for the assessment of clinical efficacy of novel
drugs to inhibit cancer development and progression. Despite the
perfect model currently does not exist and 3D approaches are
characterized by weaknesses, these greatly expand the spectrum
of cancer subtypes that might be considered for new drug
screening and for the development of personalized medicine.
In the field of bone cancers, rare and deadly diseases, this is of
paramount importance to improve the clinical outcomes.
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